Aimmune Therapeutics (AIMT) closed at $29.17 in the latest trading session, marking a -1.12% move from the prior day. This change lagged the S&P 500's daily gain of 0.65%. At the same time, the Dow ...

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Aimmune Therapeutics (AIMT) came out with a quarterly loss of $1.03 per share versus the Zacks Consensus Estimate of a loss of $1.15. This compares to loss of $0.87 per share a year ago. These figures ...

Get today's Aimmune Therapeutics Inc stock news. We cover the latest Aimmune Therapeutics Inc headlines and breaking news impacting Aimmune Therapeutics Inc stock performance.

Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds and investors’ ...

Aimmune Therapeutics (AIMT) closed at $29.17 in the latest trading session, marking a -1.12% move from the prior day. This change lagged the S&P 500's daily gain of 0.65%. At the same time, the Dow ...

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that ...

Aimmune Therapeutics (AIMT) came out with a quarterly loss of $1.06 per share in line with the Zacks Consensus Estimate. This compares to loss of $1.01 per share a year ago. These figures are adjusted ...